|
CDER Manual of Policies and Procedures (MaPP)
This page contains the current CDER Manual of Policies and Procedures in Adobe Acrobat Format (PDF).
See bottom for more information.
Contents:
Document Development and Management
- 4000.1 Developing and Issuing Manuals of
Policies and Procedures (MAPPs) (Issued 3/30/2006; Posted 3/30/2006)
- 4000.2 Developing and Issuing Guidance
(Issued 9/13/2005, Posted 10/3/2005)
- 4000.3 Submitting Proposals to the Office
of Regulatory Policy (ORP) for Early Analysis of Rulemaking Initiatives
(Issued 10/18/2001, Posted 10/23/2001)
- 4000.4 Clinical Pharmacology and Biopharmaceutics NDA
Review Template.(Issued 4/27/2004, Posted 6/24/2004).
- 4000.8 BLA
Biostatistics Biologics Licensing Application (Issued 4/20/2005, Posted 4/22/2005)
- 4000.8 NDA
Biostatistics New Drug Application Review (Issued 4/20/2005, Posted 4/22/2005)
- 4000.10 Indication-Specific Guidance Template (Issued 5/12/2005, Posted
5/12/2005)
- 4112.1 CDER/FDA Press Office Interactions
in the Preparation and Clearance of Written Documents for the Public (Issued 10/18/2001)
- 4112.2 Sharing Nonpublic Information with
Federal Government Officials (Issued 5/9/2002, Posted 7/12/2002)
- 4112.4 Procedures for Assessments Performed
by the Quality Assurance Staff (Issued 2/27/2004, Posted 3/25/2004)
- 4112.6 Review of Human Subject Research
(Issued 5/8/2006; Posted 5/8/2006)
- 4112.7 Obtaining the Services of an
Expert or Fact Witness for Criminal Cases (Issued 2/27/2004, Posted 3/25/2004)
- 4112.8 Research Coordinating Committee (RCC)
(Issued 5/22/2006, Posted 5/22/2006)
- 4114.1 Support Staff Coordinating Committee (Issued
6/11/1999, Posted 7/02/1999)
- 4114.2 Telephone Coverage Policy (Issued 11/26/2002, Posted 12/11/2002)
- 4115.1R Public Dissemination of a Summary of
the Medical and Clinical Pharmacology Reviews of Pediatric Studies (Issued
1/30/2006, Posted 1/30/2006)
- 4140.5 Submitting Issues/Documents to the Office of the Chief Counsel
(OCC) for Legal Review, Comment, or Clearance (Issued 3/2002, Posted 3/22/2002)
- 4140.6 Editing Procedures(Issued 11/27/2002, Posted 12/11/2002)
- 4143.1 Special Termination of Mandatory Debarment of an
Individual (Issued 2/25/1997, Posted 2/25/1997)
- 4150.1 Role and Procedures of the CDER Ombudsman
(Issued 10/10/2002, Posted 10/18/2002)
- 4151.1 Resolution of Disputes: Roles of Reviewers,
Supervisors, and Management: Documenting Viewsand Findings and Resolving Differences
- 4151.2 Documenting Differing Professional
Opinions and Dispute Resolution – Pilot Program (Posted 11/5/2004)
- 4151.3R Drug Safety
Oversight Board (DSB) (Issued 3/2/2007, Posted 3/2/2007)
- 4151.6 "Drug Safety Newsletter" (Issued 6/17/2008, Posted 6/19/2008)
- 4160-2 Prioritization of Requests for Training and Visits
by Foreign Regulatory Agencies and International Regulatory Organizations (Issued
5/31/2000)
- 4170-2 Submitting Non-FOIA Requests For
Document Collection and Redaction To CDER's Division of Information
Disclosure Policy (DIDP) (Issued 5/9/2002, Posted 5/15/2002)
- 4170.3 Litigation Document Control
Procedures in the Division of Information Disclosure Policy (Issued 8/10/2003,
Posted 12/11/2003)
- 4180.2 Management of the Interdisciplinary
Pharmacogenomics Review Group (IPRG) (Issued 3/16/2005, Posted 3/22/2005)
- 4180.3 Processing and Reviewing Voluntary
Genomic Data Submissions (VGDSs) (Issued 3/16/2005, Posted 3/22/2005)
- 4200.1 Consulting the
Controlled Substance Staff on INDs and ProtocolsThat Use Schedule I
Controlled Substances and Drugs (Issued 5/8/2003, Posted 5/14/2003)
- 4200.2
Forecasting Schedule I and II Substance and Drug Needs (Issued
5/8/2003, Posted 5/14/2003)
- 4200.3 Consulting the
Controlled Substance Staff on Abuse Liability, Drug Dependence, Risk
Management, and Drug Scheduling (Issued 5/8/2003, Posted 5/14/2003)
Chapters 4300 - 4400 (Reserved)
- 4501.1R Alternate Work Schedules for the Office of Training
and Communications (Revised 6/1/2007; Posted 6/7/2007)
- 4501.2R Flexible Workplace Arrangements Program
(FWAP) for the Office of Training and Communications (Revised 6/1/2007; Posted 6/7/2007)
- 4510.1 Authorization, Funding and Tracking
Speeches/Participation on Planning Committees
- 4510.2 Clearance of Speeches, Articles and Other
Communication Material (Revised 1/26/1999, Posted 1/26/1999)
- 4520.1 Communicating Drug Approval Information (Issued
3/25/1998, Posted 3/26/1998)
- 4520.2R Providing
General Consumer Information on New Molecular Entities on CDER’s Web Site
(Issued 10/1/2007, Posted 5/6/2008)
- 4550.1 Participation in the Volunteer Program for Pharmacy
Students (Issued 5/12/1998, Posted 5/14/1998)
- 4550.3 Employee Training and Development (Issued
3/13/1997, Posted 3/23/1998)
- 4550.5R Accreditation — Continuing Education
(Issued 11/16/2007, Posted 11/19/2007)
- 4550.7R Guide to the Orientation Mentoring Program
in the Center for Drug Evaluation and Research (Revised 6/1/2007; Posted 6/7/2007)
- 4601.2R Use of Alternative Workplaces
for Commissioned Corps Officers (Issued 2/22/2007, Posted 2/22/2007)
- 4601.3 Children in the Workplace (Issued
10/14/2004, Posted 10/18/2004)
- 4631.1 Supplement to Authority to Make Allotments and
Authorize the Establishment of Allowances
- 4631.2R Preparation of Purchase/Service/Stock Requisitions in iProcurement
(Issued 10/18/2007, Posted 10/19/2007)
- 4631.3R Budget Execution Planning and Reporting/Program
Management System Reports (Issued 4/8/2008, Posted 4/8/2008)
- 4634.3R Development, Maintenance, and Distribution of CDER
Organizational Charts (Issued 2/22/2007; Posted 2/22/2007)
- 4636.1R Gift Certificates/Gift Cards (Issued 11/24/2007; Posted
11/26/2007)
- 4640.1R Guide to the Assignment of Mail Routing Codes in
the Center for Drug Evaluation and Research (Revised 6/1/2007; Posted 6/7/2007)
- 4641.3R Outside Activities (Revised 7/1/2008; Posted 8/8/2008
- 4641.5 Authority to Reimburse Employees for Business Calls
Made on Personal Car Phones (Issued 4/8/2008, Posted 4/8/2008)
- 4641.8 Reimbursement for Professional Liability Insurance
(Issued 5/8/2003, Posted 5/14/2003)
- 1164 Form - Claim for Reimbursement Expenditures on
Official Business
- 4642.1R Policies and Procedures for Organizational Changes
(Issued 4/25/07
Posted 5/4/2007)
- 4651.1 On-the-Spot Cash Award
- 4651.2R Time Off Incentive Award (Revised 1/9/2008; Posted 1/9/2008)
- 4655.2 Performance Management Program (Issued 5/12/1998,
Posted 5/14/1998)
- 4656.1 CDER Expert Regulatory Scientist Peer
Review Committee (Issued 6/19/2003, Posted 10/2/2003)
- 4657-0R CDER's Time, Attendance, and Leave Recording Policy
(Issued 4/25/07
Posted 5/4/2007)
- 4657.1R Alternate Work Schedules (AWS)
(Revised 6/10/2008; Posted 6/10/2008)
- 4657.2R (FWAP) Flexiplace and Work at Home
(Revised 1/9/2008; Posted 1/9/2008)
- 4657.5R Advanced Annual and Sick Leave
(Revised 11/1/2006, Posted 11/2/2006)
- 4657.6R Granting Excused Absence (Originator: Division of
Management Services, OM) (Issued 4/25/07
Posted 5/4/2007)
- 4657.7R Leave and Absence for Hazardous Weather and Other
Emergency and Administrative Situations (Revised) (Originator: Division of Management Services, OM;
Issued Updated 5/5/2006, Posted 6/7/2006)
- 4657.9R Restoration of Forfeited Annual Leave
(Issued 1/13/2006, Posted 1/20/2006)
- 4657.10 Hazardous Weather Policy for Employees with
Disabilities (Issued 2/19/1997, Posted 2/21/1997)
- 4657.11R Religious Compensatory Time (Issued 4/25/07
Posted 5/4/2007)
- 4657.12 Voluntary Leave Transfer Program (Issued
11/7/1997, Posted 12/8/1997)
- 4700.1 Management of CDER Compliance Coordinating
Committee (Issued 3/4/1997, Posted 3/18/1997)
- 4703.1 Alternate Work Schedules for the Office of
Compliance (Originator: Director, Office of Compliance; Issued 11/19/96)
- 4703.2 Flexible Workplace Arrangements Program for the
Office of Compliance (Originator: Director, Office of Compliance; Issued 11/19/96)
- 4723.1 Standing operating Procedures for NDA/ANDA Field
alert Reports (Issued 10/30/1998, Posted 11/02/1998)
Chapter 4800.4900 (Reserved)
- 5000.4 CDER Office of Pharmaceutical Science Immediate
Office Calendar (Issued 5/8/2003,Posted 5/14/2003)
- 5000.5 Office of Pharmaceutical Science Regulatory and
Scientific Briefings (Issued 6/22/2004, Posted 6/24/2004)
- 5000.6 Office of Pharmaceutical Sciences
Coordinating Committee (OPS CC) (Issued 6/14/2006, Posted 6/14/2006)
- 5015.3 Cover Form for the Technical Review of Drug Master
Files (Issued 3/23/1998, Posted 4/7/1998)
- 5015.4 Chemistry Reviews of DMFs for Drug
Substances/Intermediates (DSI) (Issued 8/17/98, Posted 10/7/98)
- 5015-6 Review of the Same Supplemental Change to More than
One NDA or ANDA in More Than One Review Division (Issued 1/14/2000, Posted 1/19/2000)
- 5015.7 Environmental Assessments (Issued
3/6/2003, Posted 3/17/2003)
- 5020.1R Responding to Telephone Inquiries in
the Office of Generic Drugs (Issued 8/1/2006; Posted 8/3/2006)
- 5040.1 Product Quality Microbiology Information in the Common
Technical Document - Quality (CTD-Q) (Issued 5/24/2004)
- 5100.3 OCP Prioritization, Triage, and Review Process for INDs and Pre-INDs
(Issued 5/26/2006; Posted 5/30/2006)
- 5120.1 Clinical Pharmacology And Biopharmaceutics
(CPB) Briefing Criteria And Attendance Policies (Issued 10/1997, Posted 10/22/1997)
- 5200.6 Issuing and Tracking of Consults
(Issued 5/9/2001, Posted 5/14/2001)
- 5210.1 Procedure for Public Release of Bioequivalence Protocols and Reviews (MaPP
withdrawn because it is obsolete)
- 5200.8 Processing a Tentatively
Approved Application to Full Approval (Issued 6/9/2005, Posted 6/23/2005)
- 5200.9 Processing Supplements to Abbreviated
New Drug Applications Providing for Alternate Analytical Testing Laboratory
Site Changes (Issued 6/22/2005, Posted 6/23/2005)
- 5200.10 Processing of Supplemental
Applications Providing for Alternate Stand Alone Packaging Operation Site
Changes (Issued 6/9/2005, Posted 6/23/2005)
- 5200.11 Procedures for Post-Approval Commitment Tracking in the Office of Generic Drugs (Issued 7/13/2007; Posted 7/16/2007)
- 5210.2 Reassignment of Bioequivalence Reviews
(Revised 5/9/2001, Posted 5/14/2001)
- 5210.3R Productivity Documentation in the
Division of Bioequivalence (Issued 2/5/2007, Posted 2/5/2007)
- 5210.4R Review Responsibility for
Bioequivalence Studies with Clinical Endpoints Submitted in an Abbreviated
New Drug Application (Issued 12/12/2006, Posted 12/12/2006)
- 5210.5 Review of Investigational New Drug
Applications (Bio-INDs) by the Office of Generic Drugs (Issued 7/7/2006,
Posted 7/7/2006)
- 5210.6 Procedures for Review of
Bioequivalence Study Protocols (Issued 7/7/2006, Posted 7/10/2006)
- 5210.7 Inspections of Clinical Facilities
and Analytical Laboratories (Issued 12/15/2000, Posted 1/3/2001)
- 5210.8R Review of Dissolution Data in Supplemental
ANDAs (Issued 8/1/2006, Posted 8/3/2006)
- 5221.1 Requesting Methods Validation for ANDAs (Issued
3/30/2006, Posted 3/30/2006)
- 5223.2 Scoring Configuration of Generic Drug Products
- 5225.1 Guidance on the Packaging of Test Batches
- 5230.2 Review of Generic Drug Product
Labeling Requiring Input From Multiple FDA Components (Issued 7/9/2003,
Posted 10/2/2003)
- 5240.1 Requests for Expedited Review of Supplements to
Approved ANDAs and AADAs
- 5240.3R Review Order of Original ANDAs, Amendments, and Supplements (Issued and posted 10/18/2006)
- 5240.6 Telephone Requests by the Division of
Bioequivalence (Issued 12/18/2000, Posted 1/3/2001)
- 5240.7 Telephone Requests by the Divisions of Chemistry
(Issued 10/6/2003, Posted 10/8/2003)
- 5240.8 Handling of Adverse Experience
Reports and Other Generic Drug Postmarketing Reports (Issued 11/2/1005, Posted
11/2/2005)
- 5240.9 Handling and Processing Requests for Global Reviews
(Issued 11/29/2004, Posted 12/17/2004)
- 5310.2 Drafting, Circulating, and Signing Chemistry,
Manufacturing, and Controls Letters (Issued 10/27/1998, Posted 11/02/1998)
- 5310.3 Requests for Expedited Review of NDA Chemistry
Supplements (Issued 6/11/1999, Posted 7/02/1999)
- 5310.4 Procedures for Evaluating and Handling Field Alert
Reports (Posted 11/3/2000)
- 5310.6 Procedures
for Assessing Chemistry, Manufacturing, and Controls Data in NDA Annual
Reports (Issued 10/10/2002, Posted 10/18/2002)
- 5310.7R Acceptability of Standards From Alternative Compendia (Issued 11/15/2007; Posted 11/16/2007)
Chapters 5500.5900 - (Reserved)
- 6001.1 Special Government Employees Representing Sponsors
Before CDER
- 6002.1 Alternative Work Schedule
- 6002.2 Flexiplace Workplace Agreement Program
- 6002.3 Magnified Maxiflex for ORM (Issued 11/20/1997,
Posted 1/16/1998)
- 6003.1 Drug Shortage Management Issued (9/26/2006, Posted 9/28/2006)
- 6004.1 Granting Waivers Under 21 CFR 314.90 for
Postmarketing Safety Reporting Requirements Under 21 CFR 314.80 (Issued
11/16/1999, Posted 11/17/1999)
- 6004.2 Procedures for Completing and Processing
the Form "Annual Report Review: Postmarketing Study Commitment Summary
(Issued 3/10/2005, Posted 3/15/2005)
- 6007.1 Review of Botanical Drug Products
(Issued 6/7/2004, Posted 6/9/2004)
- 6010.1 NDAs: Preapproval Safety Conferences (Issued
11/15/1999, Posted 11/17/1999)
- 6010.2 Procedures for Tracking and Reviewing Phase 4
Commitments
- 6010.3 Clinical Review Template (Issued
7/9/2004, Posted 7/12/2004)
- 6010.5 NDAs: Filing Review Issues (Issued 5/8/2003,
Posted 5/14/2003)
- 6010.7 Clinical Hold/Refusal-to-File Committee (Issued 1/9/2008; Posted 1/9/2008)
- 6010.8 NDAs and BLAs: Communication to Applicants of Planned Review Timelines.
- 6020.1 Extraneous References in Product Labeling:
Exclusion of American Hospital Formulary Service (AHFS) Pharmacologic-Therapeutic
Classifications
- 6020.2R Applications for Parenteral Products in Plastic
Immediate Containters (Issued 4/25/07
Posted 5/4/2007)
- 6020.3R Review Classification Policy: Priority (P) and Standard (S) (Revised 7/18/2007; Posted 7/18/2007)
- 6020.4R Classifying Resubmissions of Original NDAs, BLAs, and Efficiacy Supplements in Response to Action Letters (Issued 11/15/2007, Posted 11/16/2007)
- 6020.5R Good Review Practice: OND Review Management of INDs and NDAs for Nonprescription Drug Products
(Issued 7/13/2007,
Posted 7/16/2007)
- 6020.7 NDAs: Foreign Language Labeling
(Issued 7/9/004, Posted 7/12/2004)
- 6020.8 Action Packages for NDAs and Efficacy
Supplements (Issued 11/13/2002, Posted 12/11/2002)
- 6020.10 NDAs: "Dear Health Care Professional"
Letters (Issued 7/2/2003, Posted 10/2/2003)
- 6020.13 Clinical Review of Drugs to Reduce
the Risk of Cancer (Issued 12/13/2005, Posted 12/15/2005)
- 6020.14 Interdisciplinary Review Team for QT Studies (Issued 10/18/2007; Posted 10/19/2007)
- 6025.1 Good Review Practices (Issued 9/5/2006; Posted 9/7/2006)
- 6025.3 Good Review Practice: Consultative Review of Drugs Regulated Within OND. (Issued 1/12/2007; Posted 1/16/2007)
- 6030.1 IND Process and Review Procedures (Issued 5/1/1998,
Posted 5/14/1998)
- 6030.2 INDs: Review of Informed Consent
Documents (Issued 11/13/2002, Posted 12/11/2002)
- 6030.4 INDs: Screening INDs (Issued
5/9/2001, Posted 5/14/2001)
- 6030.8 INDs:
Exception from Informed Consent Requirements for Emergency Research (Issued
2/4/2003, Posted 3/17/2003)
- 6050.1R Refusal to Accept Application for Filing From
Applicants in Arrears (Issued 8/14/2007; Posted 8/21/2007)
- 6060.1R Consulting the Maternal Health Team (Issued 1/5/07, Posted 1/5/07)
- 6110.1 Time and Attendance Policy for the Division of
Oncology Drug Products
- 6301.3 Overtime Policy for the Office of Drug Evaluation
III (ODE III)
- 6301.4 Time and Attendance Policy for the Office of Drug
Evaluation III (Issued 10/20/1997, Posted 12/8/1997)
- 6501.1 Flexible Workplace Arrangements Program for the
Office of Drug Evaluation V
- 6501.2 Alternate Work Schedules for the Office of Drug
Evaluation V (1/7/1996)
- 6532.1 Over-the-Counter (OTC) Labeling and Use Studies
- 6610.1 Statistical Policy Coordinating Committee (Issued
7/28/1999, Posted 7/28/1999)
- 6610.2
Responsibilities and Procedures for Statistical Review
and Evaluation of Animal Carcinogenicity Studies
(Issued 11/30/2004, Posted 12/17/2004)
Chapter 6700 - Office of Drug Safety
- 6700.1 Risk Management Plan Activities in the
Office of New Drugs and the Office of Drug Safety (Issued 9/8/2005, Posted
10/3/2005)
- 6700.2 Standards for Data Management and Analytic Processes in the Office of Surveillance and Epidemiology (OSE) (Issued 3/3/2008; Posted 3/4/2008)
- 7211.1 Drug Application Approval 501(b) Policy
- 7310.1 Medical Officer Evaluation Board
(Issued 1/10/2003, Posted 3/17/2003)
- 7400.1R Management of CDER Pharmacology/Toxicology
Coordinating Committee (Issued 10/18/2007; Posted 10/19/2007)
- 7400.4 Tertiary Review of Genetic Toxicology
Studies Resulting in a Recommendation for a Clinical Hold or Conduct of
Additional Studies (Issued 9/27/2004, Posted 9/28/2004)
- 7400.5 Management of the PTCC Education
Subcommittee (Issued 9/9/2004, Posted 9/28/2004)
- 7400.6 Management of the
PTCC Inactive (Issued 4/20/2005, Posted 4/22/2005)
- 7400.7 Management of the
PTCC Safety Pharmacology Subcommittee (issued 11/29/2004, Posted 12/17/2004)
- 7400.8 Management of the
Pharmacology and Toxicology Coordinating Committee Nonclinical
Pharmacogenomics Subcommittee (Issued 12/1/2004, Posted 12/17/2004)
- 7400.9 Management of the PTCC Reproductive and Developmental Toxicology Subcommittee (Issued 3/3/2008; Posted 3/4/2008)
- 7412.1 Management of CDER Carcinogenicity Assessment
Committee (CAC) and Executive CAC
- 7412.2 Distribution of Final Reports from the
Carcinogenicity Assessment Committee (CAC) and the Executive CAC (Issued 3/24/1997, Posted
4/8/1997)
- 7500.1R Office of New Drugs Regulatory
Project Management Coordinating Committee (Issued 5/15/2008, Posted
5/15/2008)
- 7500.2R Regulatory Project Management Site
Tours and Regulatory Interactions Program
(Issued 11/1/2006, Posted 11/2/2006)
- 7510.1 Withdrawn, superceded by the provisions of FDAMA Section 116, which went into effect on
Novemer 21, 1999 (Issued 12/1998, Posted 12/3/1998)
- 7600.2 Computer Hardware
- 7600.3 Maintaining CDER'S Electronic Submissions Docket
(Issued 10/15/1997, Posted 11/14/1997)
- 7600.4 Nomenclature Standards Committee (NSC) (Issued
4/25/1998, Posted 4/28/1998)
- 7600.6 Requesting and Accepting Non-Archivable Records in
Electronic Format for New Drug Applications (Issued 11/12/1999, Posted 11/17/1999)
- 7600.7 Processing an Electronic New Drug Application
(Issued 5/31/2000, Posted 6/5/2000)
- 7600.9 Information Management Steering Committee
(IMSC) Planning Subcommittee (Issued 3/4/2005, Posted 3/15/2005)
- 7610.1 Posting Documents on the External World Wide Web
Site
- 7610.2 Use of Government Electronic Equipment and Systems
(Issued 5/8/1998, Posted 5/14/1998)
- 7620.4 Time, Attendance, and Leave Recording
Policy in the Office of Information Technology (Issued 10/18/2001, Posted
10/23/2001)
- 7620.5 Procedures for Acquisition, Tracking,
Distribution, and Safeguarding of Gift Certificates in the Office of
Information Technology (Issued 11/20/2001, Posted 11/21/2001)
- 7700.1 Management of the Regulatory Science and Review Enhancement Committee (Issued 4/8/2008 Posted 4/8/2008)
Chapter 7800 - Administrative Management
- 7800.1R Administrative Management Coordinating Committee
(Issued 2/22/2007, Posted 2/22/2007)
These documents are in Portable Document Format
(PDF) to retain the original format. To view or print these documents, you must use the
Adobe Acrobat viewer. Acrobat is free and available directly from Adobe's website with
full installation instructions.
Back
to Top
About CDER
Last Updated: August 8, 2008 |
|